Single-Cell Techniques and Deep Learning in Predicting Drug Response

Trends Pharmacol Sci. 2020 Dec;41(12):1050-1065. doi: 10.1016/j.tips.2020.10.004. Epub 2020 Nov 2.

Abstract

Rapidly developing single-cell sequencing analyses produce more comprehensive profiles of the genomic, transcriptomic, and epigenomic heterogeneity of tumor subpopulations than do traditional bulk sequencing analyses. Moreover, single-cell techniques allow the response of a tumor to drug exposure to be more thoroughlyinvestigated. Deep learning (DL) models have successfully extracted features from complex bulk sequence data to predict drug responses. We review recent innovations in single-cell technologies and DL-based approaches related to drug sensitivity predictions. We believe that, by using insights from bulk sequencedata, deep transfer learning (DTL) can facilitate the use of single-cell data for training superior DL-based drug prediction models.

Keywords: deep learning models; deep transfer learning framework; drug response; single-cell technologies.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Computational Biology*
  • Deep Learning*
  • Epigenomics
  • Genomics
  • Pharmaceutical Preparations*
  • Pharmacology

Substances

  • Pharmaceutical Preparations